Neurocrine Biosciences
NBIX
#1393
Rank
A$19.41 B
Marketcap
$191.80
Share price
1.39%
Change (1 day)
15.05%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company